Publications by authors named "Berta Pons"

Claim this Profile
C
Characterization of antibodies in human immunoglobulin products from different regions worldwide.
Alexandra Serra, Núria Marzo, Berta Pons, Pau Maduell, Maite López

Int J Infect Dis· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flebogamma(®) DIF (intravenous immunoglobulin) purification process effectively eliminates procoagulant activities.
Marta José, Núria Marzo, Berta Pons, Aida Herrerias, Laura López

Biologicals· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines.
Cristina Teixidó, Elisabet Arguelaguet, Berta Pons, Miguel Aracil, Jose Jimeno

Int J Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between LRRK2 and 4E-BP1 protein levels in normal and malignant cells.
Berta Pons, Gemma Armengol, Mark Livingstone, Laura López, Laura Coch

Oncol Rep· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
Berta Pons, Vicente Peg, María Angeles Vázquez-Sánchez, Laura López-Vicente, Elisabet Argelaguet

Int J Oncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RSK4 inhibition results in bypass of stress-induced and oncogene-induced senescence.
Laura López-Vicente, Berta Pons, Laura Coch, Cristina Teixidó, Javier Hernández-Losa

Carcinogenesis· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of replicative and stress-induced senescence by RSK4, which is down-regulated in human tumors.
Laura López-Vicente, Gemma Armengol, Berta Pons, Laura Coch, Elisabet Argelaguet

Clin Cancer Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications.
Gemma Armengol, Federico Rojo, Josep Castellví, Carmela Iglesias, Miriam Cuatrecasas, Berta Pons

Cancer Res· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis